Publikasjonar
Nøkkelpublikasjonar fra Mohn Kreftforskingslaboratorium
MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.
Knappskog S, Lønning PE.
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.
Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS, Stoltenberg C, Romundstad P, Hveem K, Lillehaug JR, Vatten L, Devilee P, Dørum A, Lønning PE.
Siste publikasjonar
Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
Lønning PE1, Haynes BP2, Dowsett M3.
Signatures of mutational processes in human cancer.
Alexandrov LB, ....................Knappskog S,..............
Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.
Lønning PE, Knappskog S.
Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC, Wagner M, Straume O, Bjerkvig R, Eikesdal HP.
Expert Opin Ther Targets. 2013 Jan;17(1):7-20. doi: 10.1517/14728222.2013.730522. Epub 2012 Nov 2.
Lethal pneumonitis after docetaxel chemotherapy: Case report and review of the literature.
Storaas E, Holmaas G, Gravdal K, Børretzen A, Eikesdal HP.
Acta Oncol. 2012 Dec 17. [Epub ahead of print]
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Kvalheim G, Lonning PE, Naume B.Breast Cancer Res. 2012
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.
Schuster C, Eikesdal HP, Puntervoll H, Geisler J, Geisler S, Heinrich D, Molven A, Lønning PE, Akslen
Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions.
Lønning PE. Ther Adv Med Oncol. 2012 May;4(3):127-37. PMID: 22590486 [PubMed - in process]
Publikasjonar pr år